Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Verve Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 174 | 2 | 166 | −6 |
| Shares | 75.3M | 1.77K | 78.7M | +3.38M (+4.5%) |
| Value | $364.6M | $8.60K | $443.9M | +$79.3M (+21.8%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Verve Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,394,116 | $7.86M | 0.02% |
| Susquehanna Fundamental Investments, LLC | 291,383 | $1.64M | 0.03% |
| Tema ETFs LLC | 89,239 | $503.3K | 0.21% |
| Syon Capital LLC | 53,469 | $301.6K | 0.03% |
| D. E. Shaw & Co., Inc. | 37,984 | $214.2K | 0.00% |
| PEAK6 LLC | 22,500 | $126.9K | 0.00% |
| HighTower Advisors, LLC | 20,428 | $115.2K | 0.00% |
| Jain Global LLC | 19,395 | $109.4K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 18,184 | $102.6K | 0.00% |
| KLP Kapitalforvaltning AS | 17,900 | $101.0K | 0.00% |
| Impact Partnership Wealth, LLC | 12,466 | $70.3K | 0.01% |
| BNP Paribas Arbitrage, SA | 8,876 | $50.1K | 0.00% |
| Skopos Labs, Inc. | 1,810 | $10.2K | 0.00% |
| GF Fund Management Co. Ltd. | 1,778 | $10.0K | 0.00% |
| VSM Wealth Advisory, LLC | 1,000 | $5.64K | 0.00% |
| SBI Securities Co., Ltd. | 536 | $3.02K | 0.00% |
| Smartleaf Asset Management LLC | 117 | $648 | 0.00% |
| EverSource Wealth Advisors, LLC | 92 | $519 | 0.00% |
| Murphy & Mullick Capital Management Corp | 43 | $243 | 0.00% |
| The PNC Financial Services Group, Inc. | 42 | $237 | 0.00% |
Sold out (26)
Institutions that held Verve Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
Not filed for Q4 2024 yet (2)
Institutions that held Verve Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Abich Financial Wealth Management LLC | 1,189 | $5.75K |
| ClariVest Asset Management LLC | 584 | $2.85K |